These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 10508124)
1. Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid. Magklara A; Scorilas A; López-Otín C; Vizoso F; Ruibal A; Diamandis EP Clin Chem; 1999 Oct; 45(10):1774-80. PubMed ID: 10508124 [TBL] [Abstract][Full Text] [Related]
2. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids. Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A J Androl; 1999; 20(3):348-55. PubMed ID: 10386814 [TBL] [Abstract][Full Text] [Related]
3. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions. Black MH; Magklara A; Obiezu C; Levesque MA; Sutherland DJ; Tindall DJ; Young CY; Sauter ER; Diamandis EP Br J Cancer; 2000 Jan; 82(2):361-7. PubMed ID: 10646889 [TBL] [Abstract][Full Text] [Related]
4. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D. Hsieh ML; Charlesworth MC; Goodmanson M; Zhang S; Seay T; Klee GG; Tindall DJ; Young CY Cancer Res; 1997 Jul; 57(13):2651-6. PubMed ID: 9205072 [TBL] [Abstract][Full Text] [Related]
5. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications. Diamandis EP; Yousef GM; Soosaipillai AR; Grass L; Porter A; Little S; Sotiropoulou G Clin Biochem; 2000 Jul; 33(5):369-75. PubMed ID: 11018688 [TBL] [Abstract][Full Text] [Related]
6. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues. Luo LY; Grass L; Howarth DJ; Thibault P; Ong H; Diamandis EP Clin Chem; 2001 Feb; 47(2):237-46. PubMed ID: 11159772 [TBL] [Abstract][Full Text] [Related]
7. Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines. Magklara A; Grass L; Diamandis EP Breast Cancer Res Treat; 2000 Feb; 59(3):263-70. PubMed ID: 10832596 [TBL] [Abstract][Full Text] [Related]
8. Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells. Kumar A; Mikolajczyk SD; Hill TM; Millar LS; Saedi MS Prostate; 2000 Aug; 44(3):248-54. PubMed ID: 10906742 [TBL] [Abstract][Full Text] [Related]
9. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen. Black MH; Magklara A; Obiezu CV; Melegos DN; Diamandis EP Clin Chem; 1999 Jun; 45(6 Pt 1):790-9. PubMed ID: 10351987 [TBL] [Abstract][Full Text] [Related]
10. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk. Sauter ER; Lininger J; Magklara A; Hewett JE; Diamandis EP Int J Cancer; 2004 Feb; 108(4):588-91. PubMed ID: 14696124 [TBL] [Abstract][Full Text] [Related]
11. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Rittenhouse HG; Finlay JA; Mikolajczyk SD; Partin AW Crit Rev Clin Lab Sci; 1998 Aug; 35(4):275-368. PubMed ID: 9759557 [TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen in the female body: its role in breast cancer prognosis. Ulutin HC; Pak Y Radiat Med; 2000; 18(5):273-6. PubMed ID: 11128396 [TBL] [Abstract][Full Text] [Related]
14. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid. Charlesworth MC; Young CY; Miller VM; Tindall DJ J Androl; 1999; 20(2):220-9. PubMed ID: 10232657 [TBL] [Abstract][Full Text] [Related]
15. Structural comparison of prostate-specific antigen and human glandular kallikrein using molecular modeling. Bridon DP; Dowell BL Urology; 1995 May; 45(5):801-6. PubMed ID: 7538242 [TBL] [Abstract][Full Text] [Related]
16. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA. Magklara A; Scorilas A; Catalona WJ; Diamandis EP Clin Chem; 1999 Nov; 45(11):1960-6. PubMed ID: 10545066 [TBL] [Abstract][Full Text] [Related]
17. Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels. Charlesworth MC; Young CY; Klee GG; Saedi MS; Mikolajczyk SD; Finlay JA; Tindall DJ Urology; 1997 Mar; 49(3):487-93. PubMed ID: 9123724 [TBL] [Abstract][Full Text] [Related]
18. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma. Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461 [TBL] [Abstract][Full Text] [Related]
19. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity. Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595 [TBL] [Abstract][Full Text] [Related]